For example, in our results, hypoglycemic drugs are a protective factor for inflammatory bowel disease, while hypoglycemic drugs include biguanides, sulfonylureas, thiazolidinediones α- Various drugs such as glucosidase inhibitors, and GLP-1 receptor agonists (44). Here, GLP1R is linked to inflammatory bowel disease.